143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
Repetitive negative thinking linked to dementia risk

Repetitive negative thinking linked to dementia risk

by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st

Repetitive negative thinking linked to dementia risk

by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st
Improving blood vessel health in the brain may help combat Alzheimer's

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i
FDA approves Vyalev for advanced Parkinson's disease

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an
Researchers identify 10 pesticides toxic to neurons involved in Parkinson's

Researchers identify 10 pesticides toxic to neurons involved in Parkinson's

by University of California, Los AngelesDescription of agricultural pesticide use in the study area, including geography of applications, number of unique active ingredients applied by year, tota

Researchers identify 10 pesticides toxic to neurons involved in Parkinson's

by University of California, Los AngelesDescription of agricultural pesticide use in the study area, including geography of applications, number of unique active ingredients applied by year, tota
Unlikely that high cholesterol or statins increase the risk of dementia

Unlikely that high cholesterol or statins increase the risk of dementia

by Cecilie Bakken Høstmark,University of OsloIn professor Kjetil Retterstøl's new study, he found that neither high cholesterol itself nor statins can explain an increased risk of developing

Unlikely that high cholesterol or statins increase the risk of dementia

by Cecilie Bakken Høstmark,University of OsloIn professor Kjetil Retterstøl's new study, he found that neither high cholesterol itself nor statins can explain an increased risk of developing
Challenging assumptions on the economic costs of dementia

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in
New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainResearchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that

New atlas aims to replace uniform traumatic brain injury treatment with precision medicine

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainResearchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that
Over 7 million US seniors have mental declines that threaten financial skills

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite
Helping children and young people isolated by young onset dementia find a voice

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia
New insight into role of amyloid beta in Alzheimer's disease

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul